Global Mofy Reports YoY $9.8 million Increase in Net Income for the Six Months Ended March 31, 2024
July 23, 2024 08:00 ET
|
Global Mofy Metaverse Limited
Revenue achieved a record of $19.9 million, up 55.3% from $12.8 Million.Gross Profit Increased by 135.1% to $11.8 Million from $5.0 Million.Gross Margin Expanded to 59.3% from 39.2%.EPS Surged by...
Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
July 23, 2024 08:00 ET
|
Aquestive Therapeutics, Inc.
WARREN, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...
Data Intelligence Firm Cyabra Plans to List on NASDAQ Through a Business Combination with Trailblazer Merger Corporation I
July 23, 2024 08:00 ET
|
Trailblazer Merger Corporation I
Cyabra’s AI Tools Empower Corporations and Governments in the Fight Against Disinformation CampaignsElon Musk Engaged Cyabra to Analyze the Amount of Bot Activity Prior to His Acquisition of Twitter1 ...
Captivision, 출자전환 통해 재무상태 강화
July 23, 2024 08:00 ET
|
Captivision Inc.
약 420만 달러 상당의 미상환 부채를 주당전환가액 3.00달러를 책정해 자본전환Captivision Korea의 사모 채권 발행을 통해 약 220만 달러 조달 마이애미 & 서울, July 23, 2024 (GLOBE NEWSWIRE) -- 건축용 미디어 글라스 분야를 선도하는 Captivision Inc. (이하 “Captivision” 또는...
Synchronoss Technologies Announces Second Quarter 2024 Earnings Call Date
July 23, 2024 08:00 ET
|
Synchronoss Technologies, Inc.
BRIDGEWATER, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will...
FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
July 23, 2024 07:53 ET
|
Mesoblast Limited
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States Food...
Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
July 23, 2024 07:30 ET
|
Rhythm Pharmaceuticals, Inc.
BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families...
Ollie’s Partners with Sunbit to Offer a New Co-Branded Visa Credit Card
July 23, 2024 07:30 ET
|
Ollie's Bargain Outlet Holdings, Inc.
HARRISBURG, Pa., July 23, 2024 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced that it has partnered with Sunbit, a leading financial...
BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
July 23, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases,...
DraftKings Plans to Launch Mobile Sports Betting in Washington D.C.
July 23, 2024 07:30 ET
|
DK Crown Holdings Inc.
BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Today, DraftKings Inc. (Nasdaq: DKNG) announced its intention to launch its top-rated online sportsbook in Washington D.C., pending licensure and regulatory...